|
|
- 2019
Epidemiology of Chemotherapy-Induced Anemia in Patients with Non-Hodgkin LymphomaDOI: 10.7812/TPP/18-252 Keywords: anemia, erythropoiesis-stimulating agents, lymphoma, non-Hodgkin lymphoma, transfusion Abstract: Anemia is a common adverse effect of myelosuppressive chemotherapy, and the development of chemotherapy-induced anemia (CIA) is more common in patients with hematologic malignant tumors
|
